$IVDA
Iveda Solutions, Inc. Stock $ivda

$ivda Overview Financials Valuation SEC Filings Company Website

2015 Q3 Form 10-Q Financial Statement

#000114420415049256 Filed on August 14, 2015

Income Statement

Concept	2015 Q3	2015 Q2	2014 Q4
Revenue	$823.4K	$775.6K	$970.0K
YoY Change	68.38%	120.79%	-29.2%
Cost Of Revenue	$633.9K	$634.9K	$690.0K
YoY Change	59.61%	102.27%	-34.91%
Gross Profit	$189.4K	$140.7K	$280.0K
YoY Change	106.28%	276.26%	-9.68%
Gross Profit Margin	23.01%	18.14%	28.87%
Selling, General & Admin			$1.250M
YoY Change			-80.97%
% of Gross Profit			446.43%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$39.33K	$52.18K	$60.00K
YoY Change	-34.45%	-13.04%	20.0%
% of Gross Profit	20.76%	37.08%	21.43%
Operating Expenses	$854.6K	$967.8K	$1.260M
YoY Change	-29.96%	-36.79%	-38.54%
Operating Profit	-$665.2K	-$827.1K	-$980.0K
YoY Change	-41.05%	-44.63%	-43.68%
Interest Expense	-$293.3K	$28.89K	-$150.0K
YoY Change	-309.4%	-75.91%	-400.0%
% of Operating Profit
Other Income/Expense, Net		-$40.41K
YoY Change		-48.97%
Pretax Income	-$953.8K	-$867.5K	-$1.460M
YoY Change	-20.6%	-44.85%	-42.29%
Income Tax	-$120.00	$12.85K	$0.00
% Of Pretax Income
Net Earnings	-$953.7K	-$880.3K	-$1.460M
YoY Change	-20.62%	-44.59%	-40.65%
Net Earnings / Revenue	-115.83%	-113.51%	-150.52%
Basic Earnings Per Share		-$0.03
Diluted Earnings Per Share	-$34.45K	-$32.15K	-$53.46K
COMMON SHARES
Basic Shares Outstanding	27.45M shares		27.31M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2015 Q3	2015 Q2	2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$242.8K	$684.6K	$250.0K
YoY Change	-13.29%	2.17%	-55.36%
Cash & Equivalents	$242.8K	$684.6K	$87.90K
Short-Term Investments			$160.0K
Other Short-Term Assets	$1.141M	$1.107M	$647.7K
YoY Change	-32.49%	-13.54%	301.61%
Inventory	$350.0K	$420.8K	$387.9K
Prepaid Expenses
Receivables	$539.6K	$1.295M	$358.8K
Other Receivables	$0.00	$0.00	$110.0K
Total Short-Term Assets	$2.273M	$3.507M	$2.461M
YoY Change	-16.72%	18.89%	-4.81%
LONG-TERM ASSETS
Property, Plant & Equipment	$331.1K	$365.7K	$532.5K
YoY Change	-40.87%	-37.48%	13.02%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments			$50.00K
YoY Change
Other Assets	$191.1K	$212.4K	$364.3K
YoY Change	-52.23%	-48.18%	-23.41%
Total Long-Term Assets	$633.9K	$694.8K	$1.023M
YoY Change	-41.85%	-38.98%	-6.4%
TOTAL ASSETS
Total Short-Term Assets	$2.273M	$3.507M	$2.461M
Total Long-Term Assets	$633.9K	$694.8K	$1.023M
Total Assets	$2.907M	$4.202M	$3.485M
YoY Change	-23.89%	2.77%	-5.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.958M	$2.225M	$2.166M
YoY Change	-9.79%	6.44%	-8.16%
Accrued Expenses			$970.0K
YoY Change			-41.26%
Deferred Revenue
YoY Change
Short-Term Debt	$203.9K	$1.037M	$1.081M
YoY Change	-78.98%	125.37%	1692.14%
Long-Term Debt Due		$0.00	$34.61K
YoY Change		-100.0%	-78.92%
Total Short-Term Liabilities	$3.020M	$3.761M	$3.968M
YoY Change	-18.59%	30.58%	45.74%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Other Long-Term Liabilities	$558.2K	$463.1K	$270.0K
YoY Change	248.85%	189.42%	285.71%
Total Long-Term Liabilities	$558.2K	$463.1K	$0.00
YoY Change	-84.32%	-86.66%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.020M	$3.761M	$3.968M
Total Long-Term Liabilities	$558.2K	$463.1K	$0.00
Total Liabilities	$3.579M	$4.224M	$3.968M
YoY Change	-50.78%	-33.59%	28.54%
SHAREHOLDERS EQUITY
Retained Earnings			-$27.49M
YoY Change			26.09%
Common Stock		$30.02M	$27.26M
YoY Change			21.95%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$671.3K	-$21.83K	-$756.4K
YoY Change
Total Liabilities & Shareholders Equity	$2.907M	$4.202M	$3.485M
YoY Change	-23.89%	2.77%	-5.28%

Cashflow Statement

Concept	2015 Q3	2015 Q2	2014 Q4
OPERATING ACTIVITIES
Net Income	-$953.7K	-$880.3K	-$1.460M
YoY Change	-20.62%	-44.59%	-40.65%
Depreciation, Depletion And Amortization	$39.33K	$52.18K	$60.00K
YoY Change	-34.45%	-13.04%	20.0%
Cash From Operating Activities	-$242.1K	-$1.147M	-$800.0K
YoY Change	-75.79%	-33.31%	3.9%
INVESTING ACTIVITIES
Capital Expenditures	-$2.400K	-$5.060K	-$20.00K
YoY Change	-94.0%	-92.77%	-71.43%
Acquisitions
YoY Change
Other Investing Activities	$5.980K	$5.350K
YoY Change
Cash From Investing Activities	$3.570K	$300.00	-$30.00K
YoY Change	-111.9%	-100.43%	-57.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-196.6K	251.8K	640.0K
YoY Change	-131.2%	-83.76%	93.94%
NET CHANGE
Cash From Operating Activities	-242.1K	-1.147M	-800.0K
Cash From Investing Activities	3.570K	300.0	-30.00K
Cash From Financing Activities	-196.6K	251.8K	640.0K
Net Change In Cash	-435.1K	-895.0K	-190.0K
YoY Change	8.77%	272.9%	-62.75%
FREE CASH FLOW
Cash From Operating Activities	-$242.1K	-$1.147M	-$800.0K
Capital Expenditures	-$2.400K	-$5.060K	-$20.00K
Free Cash Flow	-$239.7K	-$1.142M	-$780.0K
YoY Change	-75.03%	-30.79%	11.43%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	112009	USD
CY2015Q2	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	0	USD
CY2015Q2	us-gaap	Other Assets OtherAssets	329110	USD
CY2014Q4	us-gaap	Other Assets OtherAssets	490986	USD
CY2015Q2	us-gaap	Assets Assets	4202020	USD
CY2014Q4	us-gaap	Assets Assets	3484874	USD
CY2015Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2224650	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2166246	USD
CY2015Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	430000	USD
CY2014Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	575000	USD
CY2015Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	1036713	USD
CY2014Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	1080500	USD
CY2015Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	69418	USD
CY2014Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	34610	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	1141218	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	402016	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	145251	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	302638	USD
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	14915	USD
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	21472	USD
	us-gaap	Revenues Revenues	1301384	USD
	us-gaap	Revenues Revenues	726126	USD
	us-gaap	Cost Of Revenue CostOfRevenue	993552	USD
	us-gaap	Cost Of Revenue CostOfRevenue	524401	USD
	us-gaap	Gross Profit GrossProfit	307832	USD
	us-gaap	Gross Profit GrossProfit	201725	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1675895	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2857089	USD
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	9126	USD
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	10709	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	42591	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	42001	USD
	dei	Entity Registrant Name EntityRegistrantName	Iveda Solutions, Inc.
	dei	Entity Central Index Key EntityCentralIndexKey	0001397183
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Trading Symbol TradingSymbol	IVDA
CY2015Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	27451690	shares
CY2015Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3760781	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3968365	USD
CY2015Q2	us-gaap	Common Stock Value CommonStockValue	275	USD
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	273	USD
CY2015Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	30017724	USD
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	27261762	USD
CY2015Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-33519	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-35615	USD
CY2015Q2	us-gaap	Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock	492194	USD
CY2014Q4	us-gaap	Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock	492194	USD
CY2015Q2	ivda	Dividends Payable Noncurrent DividendsPayableNoncurrent	463072	USD
CY2014Q4	ivda	Dividends Payable Noncurrent DividendsPayableNoncurrent	272901	USD
CY2015Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	726695	USD
CY2014Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	191705	USD
CY2015Q2	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	1955	USD
CY2014Q2	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	15720	USD
CY2015Q2	us-gaap	Revenues Revenues	775561	USD
CY2014Q2	us-gaap	Revenues Revenues	351262	USD
CY2015Q2	us-gaap	Cost Of Revenue CostOfRevenue	634857	USD
CY2014Q2	us-gaap	Cost Of Revenue CostOfRevenue	313867	USD
CY2015Q2	us-gaap	Gross Profit GrossProfit	140704	USD
CY2014Q2	us-gaap	Gross Profit GrossProfit	37395	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-827084	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1493689	USD
CY2015Q2	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	4683	USD
CY2014Q2	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	8475	USD
CY2015Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	5659	USD
CY2014Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	30401	USD
CY2015Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	7594	USD
CY2014Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	1874	USD
CY2015Q2	us-gaap	Interest Expense InterestExpense	28894	USD
CY2014Q2	us-gaap	Interest Expense InterestExpense	119949	USD
CY2015Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-40412	USD
CY2014Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-79199	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-867496	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1572888	USD
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12853	USD
CY2014Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15879	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-880349	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	-1588767	USD
CY2015Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.03
CY2014Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.06
CY2015Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	27380701	shares
CY2014Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	26849456	shares
CY2014Q2	us-gaap	Operating Expenses OperatingExpenses	1531084	USD
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	967788	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	13677	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1877	USD
	us-gaap	Interest Expense InterestExpense	66925	USD
	us-gaap	Interest Expense InterestExpense	175953	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-30985	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-121366	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2978455	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12853	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15879	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1719733	USD
	us-gaap	Net Income Loss NetIncomeLoss	-2994334	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.06
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.11
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	27344729	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	26814103	shares
	us-gaap	Operating Expenses OperatingExpenses	3058814	USD
	us-gaap	Operating Expenses OperatingExpenses	1983727	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	565	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1834	USD
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-879784	USD
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1586933	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	2096	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	33	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1717637	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2994301	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	109302	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	110952	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	13152	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	41227	USD
	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	42591	USD
	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	42001	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	84000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	195000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	924865	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	104288	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	30715	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	193606	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-93989	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-9821	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-46905	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-271636	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2437022	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3231777	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5055	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	214378	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	298	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-214378	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-461896	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-169834	USD
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-68406	USD
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	3479750	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8636	USD
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-145000	USD
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	88000	USD
	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	-35270	USD
	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	-85694	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	98978	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3031746	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3559587	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	1632	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	439	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	596654	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	7869	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	0	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	113871	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	559729	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	673600	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3085	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3936	USD
	ivda	Issuance Of Common Stock Warrants For Interest IssuanceOfCommonStockWarrantsForInterest	14826	USD
	ivda	Issuance Of Common Stock Warrants For Interest IssuanceOfCommonStockWarrantsForInterest	0	USD
	ivda	Inventory Valuation Allowance InventoryValuationAllowance	1000	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	2821482	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
	ivda	Inventory Valuation Allowance InventoryValuationAllowance	0	USD
CY2015Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2015Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5953227	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.03
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	291000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.77
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	161208	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.41
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6083019	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.01
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	6017894	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.02
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.77
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2015Q2	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	1.02
CY2015Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	6017894	shares
CY2015Q2	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	1.01
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P7Y
CY2015Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	6083019	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.1835	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0199	pure
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2015Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	212444	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	364320	USD
CY2015Q2	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-29454	USD
CY2014Q2	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-29454	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	5353	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	0	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	1961	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	2956	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	0	USD
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.5in"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt 0.25in" align="justify"><strong><u><font style="FONT-SIZE: 10pt"> Concentrations</font></u></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.75in" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.75in" align="justify"><font style="FONT-SIZE: 10pt">Financial instruments, which potentially subject us to concentrations of credit risk, consist principally of cash and cash equivalents and trade accounts receivable.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.7pt; MARGIN: 0in 0in 0pt 54.6pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.75in" align="justify"><font style="FONT-SIZE: 10pt">Substantially all cash is deposited in two financial institutions, one in the United States and one in Taiwan. At times, amounts on deposit in the United States may be in excess of the FDIC insurance limit. Deposits in Taiwan financial institutions are insured by CDIC (“Central Deposit Insurance Corporation”) with maximum coverage of NTD <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3</font> million. At times, amounts on deposit in Taiwan may be in excess of the CDIC insurance limit.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.7pt; MARGIN: 0in 0in 0pt 54.6pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.75in" align="justify"><font style="FONT-SIZE: 10pt">Accounts receivable are unsecured, and we are at risk to the extent such amount becomes uncollectible. We perform periodic credit evaluations of our customers’ financial condition and generally do not require collateral. U.S.-based segment revenue from two customers represented approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 31</font>% of total revenue for the six months ended June 30, 2015, and two customers represented approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 83</font>% of the total U.S.-based segment accounts receivable at June 30, 2015. Taiwan-based segment revenue from two customers represented approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 72</font>% of total revenue for the six months ended June 30, 2015, and two customers represented approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 51</font>% of total Taiwan-based segment accounts receivable at June 30, 2015.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.75in" align="justify"><strong><u><font style="FONT-SIZE: 10pt"> Reclassification</font></u></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.75in" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.75in" align="justify"><font style="FONT-SIZE: 10pt">Certain amounts in 2014 may have been reclassified to conform to the 2015 presentation.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	584883	USD
CY2015Q2	us-gaap	Inventory Gross InventoryGross	420823	USD
CY2014Q2	us-gaap	Inventory Gross InventoryGross	525322	USD
CY2014Q2	us-gaap	Assets Assets	4088646	USD
	ivda	Cash Cdic Insured Limit CashCdicInsuredLimit	3000000	TWD
	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	0.10
	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	1.75
	ivda	Warrants To Purchase Common Stock Value WarrantsToPurchaseCommonStockValue	7883303	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	22127032	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11807271	shares
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2015Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2015Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2015Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27451690	shares
CY2015Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27451690	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27308357	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27308357	shares
	us-gaap	Interest Paid InterestPaid	37422	USD
	us-gaap	Interest Paid InterestPaid	18339	USD
	ivda	Warrants Issued For Interest Expense WarrantsIssuedForInterestExpense	7327	USD
	ivda	Warrants Issued For Interest Expense WarrantsIssuedForInterestExpense	0	USD
	ivda	Common Stock Warrants Issued As Deferred Finance Costs CommonStockWarrantsIssuedAsDeferredFinanceCosts	0	USD
	ivda	Common Stock Warrants Issued As Deferred Finance Costs CommonStockWarrantsIssuedAsDeferredFinanceCosts	13430	USD
	ivda	Discount On Convertible Debt DiscountOnConvertibleDebt	0	USD
	ivda	Discount On Convertible Debt DiscountOnConvertibleDebt	112784	USD
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0	USD
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	126214	USD
	us-gaap	Stock Issued1 StockIssued1	7500	USD
	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2015Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	52178	USD
CY2015Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	915610	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1874424	USD
	us-gaap	Property Plant And Equipment Gross Period Increase Decrease PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease	-5055	USD
	us-gaap	Property Plant And Equipment Gross Period Increase Decrease PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease	214378	USD

Files In Submission

Name	View Source	Status
0001144204-15-049256-index-headers.html	Edgar Link	pending
0001144204-15-049256-index.html	Edgar Link	pending
0001144204-15-049256.txt	Edgar Link	pending
0001144204-15-049256-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
ivda-20150630.xml	Edgar Link	completed
ivda-20150630.xsd	Edgar Link	pending
ivda-20150630_cal.xml	Edgar Link	unprocessable
ivda-20150630_def.xml	Edgar Link	unprocessable
ivda-20150630_lab.xml	Edgar Link	unprocessable
ivda-20150630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v417588_10q.htm	Edgar Link	pending
v417588_ex31-1.htm	Edgar Link	pending
v417588_ex31-2.htm	Edgar Link	pending
v417588_ex32-1.htm	Edgar Link	pending
v417588_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IVDA
Iveda Solutions, Inc. Stock $ivda

2015 Q3 Form 10-Q Financial Statement

#000114420415049256 Filed on August 14, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IVDA Iveda Solutions, Inc. Stock $ivda

2015 Q3 Form 10-Q Financial Statement

#000114420415049256 Filed on August 14, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IVDA
Iveda Solutions, Inc. Stock $ivda